Genetic Analysis AS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genetic Analysis AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10899
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and bacterial imbalances in the digestive system of irritable bowel syndrome and IBD patients. It services include gut microbiota, patient testing and clinical research services. Genetic Analysis provides gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients. The company’s technology utilizes common and variable DNA sequences within specified 16S rRNA gene of the bacteria to identify the different bacteria. Its GA-map ProbeTool software program uses search mechanisms to find combinations of DNA probes that can be used in the test. The company’s GA-map technology supports to generate profiles of a person’s microbiota and correlate such profiles to different health conditions. Genetic Analysis is headquartered in Oslo, Norway.

Genetic Analysis AS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genetic Analysis AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genetic Analysis AS, Medical Devices Deals, 2012 to YTD 2018 9
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Genetic Analysis Raises US$2 Million In Venture Financing 11
Partnerships 12
Genetic Analysis Enters into Agreement with Bio-Rad Labs 12
Licensing Agreements 13
Applied BioCode Enters Into Licensing Agreement With Genetic Analysis 13
Genetic Analysis AS – Key Competitors 14
Genetic Analysis AS – Key Employees 15
Genetic Analysis AS – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Genetic Analysis AS, Pharmaceuticals & Healthcare, Key Facts 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genetic Analysis AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genetic Analysis AS, Deals By Therapy Area, 2012 to YTD 2018 8
Genetic Analysis AS, Medical Devices Deals, 2012 to YTD 2018 9
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genetic Analysis Raises US$2 Million In Venture Financing 11
Genetic Analysis Enters into Agreement with Bio-Rad Labs 12
Applied BioCode Enters Into Licensing Agreement With Genetic Analysis 13
Genetic Analysis AS, Key Competitors 14
Genetic Analysis AS, Key Employees 15

List of Figures
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genetic Analysis AS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Genetic Analysis AS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Marriott International Inc:企業のM&A・事業提携・投資動向
    Marriott International Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Marriott International Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Monopar Therapeutics LLC:企業のM&A・提携動向(医療分野)
    Summary Monopar Therapeutics LLC (Monopar) is a biopharmaceutical company that focused on the development of orphan oncology compounds. The company’s lead compound, huATN-658, an anti-urokinase plasminogen activator receptor (uPAR) monoclonal antibody intended for the potential treatment of various …
  • Senvion SE:企業のM&A・提携動向(エネルギー分野)
    Summary Senvion SE (Senvion), a subsidiary of Centerbridge Partners, LP, is a manufacturer of onshore and offshore wind turbines. It develops produces and markets wind turbines for almost any location with rated outputs. The company also provides project-specific solutions related to turnkey, servic …
  • Aevi Genomic Medicine Inc (GNMX):企業の財務・戦略的SWOT分析
    Summary Aevi Genomic Medicine Inc (Aevi), formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and life-altering diseases.The company provides pipeline products such as AEVI-001 and AEVI-002. Its lead product AEVI-001, is a glut …
  • Air Transport Services Group, Inc.:企業の戦略・SWOT・財務分析
    SummaryAir Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the c …
  • IRIS Software Group, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' IRIS Software Group, Ltd. Merge …
  • Richardson Electronics, Ltd. (RELL):企業の財務及び戦略的SWOT分析
    Summary Richardson Electronics, Ltd. (Richardson Electronics) is an engineered solution and electronic component provider that offers technical expertise and engineered solutions. The company offers products such as capacitors, electromechanical products, electron tubes and vacuum devices, electro-o …
  • PotlatchDeltic Corporation (PCH):企業の財務・戦略的SWOT分析
    PotlatchDeltic Corporation (PCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Tessi S.A. (TES):企業の財務・戦略的SWOT分析
    Tessi S.A. (TES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • AEI Services LLC:企業のM&A・提携動向(エネルギー分野)
    Summary AEI Services LLC (AEI), formerly Ashmore Energy International, is an energy utility company that owns, develops and operates power generation assets. The company also carries out the natural gas transportation and distribution businesses in emerging markets. Its power generation portfolio co …
  • Palliser Oil & Gas Corporation (PXL)(石油・ガス分野):企業M&A動向
    Summary Palliser Oil & Gas Corporation (Palliser Oil & Gas) is an oil and gas company. It focuses on the acquisition, development and production of high netback heavy oil reserves especially in the greater Lloydminster Area of Alberta and Saskatchewan. The company also produces natural gas from the …
  • Emtec, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Emtec, Inc. Mergers and Acquisi …
  • Asahi Intecc Co., Ltd. (7747):(医療機器分野)企業M&A及び提携動向
    Summary Asahi Intecc Co., Ltd. (Asahi) is a medical device company. The company develops, manufactures, and sells ultrafine stainless wire rope and terminal processed wire ropes. Its products include PTCA guide wire, peripheral guide wire, neuro intervention wire, guiding catheter, PTCA balloon cath …
  • Pernod Ricard SA:企業のM&A・提携・投資分析
    Pernod Ricard SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pernod Ricard SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Mahindra and Mahindra Limited:企業の戦略・SWOT・財務分析
    SummaryMahindra and Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • Government of Tamil Nadu:企業のM&A・提携動向(エネルギー分野)
    Summary Government of Tamil Nadu (GTN) is a governing authority for the Indian State of Tamil Nadu that offers various utility services. The authority operates through its various departments including adi dravidar and tribal welfare; agriculture; BC, MBC and minorities welfare; commercial taxes and …
  • Shanghai Electric Power Co., Ltd. (600021):企業概要、財務及び戦略的SWOT分析
    Summary Shanghai Electric Power Co., Ltd. (Shanghai Electric Power) is an energy company. The company generates and sells electricity and thermal power. It generates electricity from coal-fired plants, gas-fired plants, IGCC, wind and solar power units. Shanghai Electric Power also undertakes power …
  • E.ON Italia S.p.A.:企業のM&A・提携動向(エネルギー分野)
    Summary E.ON Italia S.p.A. (E.ON) is an energy utility company. The company carries out electricity generation and distribution to customer base. E.ON is the Italian regional unit of E.ON SE, an integrated energy company. E.ON has classified business operations into four divisions, namely, Generatio …
  • Cannabis Science, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cannabis Science, Inc. Mergers …
  • Valero Energy Corporation:企業のM&A・提携・投資分析
    Valero Energy Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Valero Energy Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆